Patient Questions · Pharmacy Safety

503A vs 503B Compounding Pharmacies: What’s the Difference?

Both make compounded medications legally — the difference is who oversees them and how. Here is the honest, current breakdown, and why it decides whether your peptide or GLP-1 therapy is legitimate.

Medically reviewed by Charles Kamen, MD, board-certified neurologist ·

A 503A pharmacy is a traditional, state-licensed compounding pharmacy that prepares medications for an individual patient with a valid prescription. A 503B pharmacy is an FDA-registered outsourcing facility that can compound in larger batches under current Good Manufacturing Practice (cGMP) — the same quality standard required of conventional drug manufacturers. Both categories are defined in the Federal Food, Drug, and Cosmetic Act and were clarified by the Drug Quality and Security Act of 2013, passed after a 2012 contaminated-compounding tragedy.

For anyone researching peptide therapy or compounded GLP-1 medications, this distinction is the most important safety question to ask — far more useful than any marketing claim. Legitimate compounded medications come from licensed 503A or 503B pharmacies. Vials sold online as “research use only” come from neither, and are not made or tested for human use.

503A vs 503B compounding pharmacies — LiveNow Longevity, current as of June 20, 2026.
Dimension503A — Traditional Compounding Pharmacy503B — FDA-Registered Outsourcing Facility
Legal authoritySection 503A of the Federal Food, Drug, and Cosmetic ActSection 503B, added by the Drug Quality and Security Act of 2013
What it isA traditional compounding pharmacy licensed by a state board of pharmacyAn FDA-registered "outsourcing facility" that voluntarily registers with the FDA
Prescription requirementCompounds for an identified individual patient pursuant to a valid prescriptionMay compound in bulk without a patient-specific prescription, for office use
Manufacturing standardState pharmacy practice standards and USP compounding chaptersCurrent Good Manufacturing Practice (cGMP) — the same standard as drug manufacturers
FDA inspectionPrimarily overseen by the state board; FDA inspects for causeRoutinely inspected by the FDA on a risk-based schedule
Adverse-event reportingPer state requirementsRequired to report adverse events to the FDA
Typical use casePatient-specific formulations — a custom strength, a dye-free version, an allergy-friendly baseLarger-batch sterile and non-sterile preparations distributed to clinics

Source: Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act, as amended by the Drug Quality and Security Act of 2013, and current FDA compounding guidance. Reviewed by Charles Kamen, MD. Verify a pharmacy’s current registration on the FDA registered outsourcing facilities list.

How do you tell a licensed pharmacy from a gray-market vendor?

A legitimate clinic dispenses only through a named, licensed 503A or 503B pharmacy, after a physician evaluation and a valid prescription, with third-party purity and potency testing available. Gray-market sellers do the opposite. The checklist below is what separates the two.

Legitimate: medication is dispensed by a named, licensed 503A or 503B pharmacy you can verify

Legitimate: a valid prescription follows a physician evaluation — no checkout cart for raw vials

Legitimate: certificates of analysis show third-party purity and potency testing

Red flag: products labeled "research use only" or "not for human consumption"

Red flag: bulk active ingredient or vials sold direct to consumers with no prescription

Red flag: the seller cannot name the pharmacy that made the preparation

503A vs 503B — FAQ

What is the difference between a 503A and a 503B compounding pharmacy?

A 503A pharmacy is a traditional state-licensed compounding pharmacy that prepares medications for an identified individual patient pursuant to a valid prescription. A 503B pharmacy is an FDA-registered outsourcing facility that may compound larger batches without a patient-specific prescription and must follow current Good Manufacturing Practice (cGMP), the same quality standard required of conventional drug manufacturers. Both categories are defined in the Federal Food, Drug, and Cosmetic Act — 503A and 503B refer to the sections that authorize them.

Is a 503B pharmacy FDA-approved?

No compounded drug is "FDA-approved," including those made by 503B outsourcing facilities. What distinguishes a 503B facility is that it is FDA-registered and FDA-inspected, and is required to manufacture under cGMP standards. Registration and approval are not the same thing: the facility is overseen by the FDA, but the individual compounded preparations it makes have not gone through the FDA new-drug approval process.

Why does the 503A vs 503B distinction matter for peptide and GLP-1 therapy?

It matters because it tells you how a medication was made and overseen. Legitimate compounded peptides and GLP-1 preparations are dispensed through licensed 503A or FDA-registered 503B pharmacies, with documentation, sterility standards, and third-party purity and potency testing. Products sold online as "research use only" peptides come from neither — they are not made, tested, or labeled for human use, and there is no way to verify what is in them.

How can I tell if a clinic uses a licensed compounding pharmacy?

A legitimate clinic will name the licensed 503A or 503B pharmacy it works with, dispense medication only after a physician evaluation and valid prescription, and be able to provide certificates of analysis showing third-party purity and potency testing. Warning signs of gray-market sourcing include selling vials directly without a prescription, labeling products "research use only" or "not for human consumption," and an inability to identify the pharmacy that made the preparation.

Are compounded medications from 503A and 503B pharmacies legal?

Yes. Compounding under Sections 503A and 503B is an established, legal part of U.S. medicine when done by licensed pharmacies for legitimate medical needs, such as when an FDA-approved product is unavailable or a patient needs a formulation that is not commercially manufactured. What is not legitimate is the sale of bulk active ingredient or "research-use-only" product to consumers outside the pharmacy framework.

Does LiveNow Longevity use 503A or 503B pharmacies?

LiveNow Longevity dispenses through licensed U.S. 503A and 503B compounding pharmacies, with third-party purity and potency testing. Service fees cover physician oversight only; medications are dispensed directly by the licensed pharmacy at pass-through cost. This is the same sourcing standard a patient should expect from any legitimate physician-led peptide or GLP-1 practice.

Related reading: Which peptides are FDA-approved? · Is peptide therapy safe? · FDA peptide compounding status

Physician-Led in Las Vegas

Sourcing you can verify, from a named physician

LiveNow Longevity dispenses through licensed U.S. 503A and 503B pharmacies with third-party testing. Start with an $88 medical evaluation and Dr. Kamen will walk you through exactly where your medication comes from.

Visit our clinic in Las Vegas

Ready to Start Your Longevity Journey?

Book your $88 evaluation with Dr. Kamen today — online, by phone, or by text.

Book Your $88 Evaluation

Prefer to talk? Call (702) 808-2650 or text us to book.

physician-led peptide therapy Las Vegas — visit our clinic